Praxis Precision Medicines (PRAX) Net Cash Flow (2019 - 2026)

Praxis Precision Medicines' Net Cash Flow history runs 8 years deep, the most recent figure standing at $179.0 million for Q1 2026.

• In Q1 2026, Net Cash Flow rose 459.41% year-over-year to $179.0 million; the TTM figure through Mar 2026 stood at $370.8 million (up 2628.83% YoY), while the FY2025 annual figure was $142.0 million, up 5.88% from the prior year.
• Net Cash Flow was $179.0 million for Q1 2026 at Praxis Precision Medicines, down from $207.8 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $207.8 million in Q4 2025 to a low of -$61.4 million in Q1 2022.
• Historically, Net Cash Flow has averaged $23.4 million across 5 years, with a median of -$825000.0 in 2022.
• The sharpest annual moves came in 2023 and 2026: Net Cash Flow slumped 2298.18% in 2023, then soared 459.41% in 2026.
• A 5-year view of Net Cash Flow shows it stood at -$825000.0 in 2022, then plunged by 2298.18% to -$19.8 million in 2023, then surged by 336.17% to $46.7 million in 2024, then soared by 344.72% to $207.8 million in 2025, then retreated by 13.86% to $179.0 million in 2026.
• The last three Net Cash Flow figures came in at $179.0 million (Q1 2026), $207.8 million (Q4 2025), and -$7.9 million (Q3 2025), per Business Quant data.